The 40 Under 40, Evan Hill of Cravath, Swaine & Moore is honored for his work in bankruptcy and restructuring.

But CEO Jacob Thaysen told Yahoo Finance he remains positive about the company's near-term growth. Why? Because, in part, pharmaceutical companies can provide a new market.  "Now, we're shifting from ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s nonprofit acquires 23andMe.

According to Wojcicki, panda parenting, an answer to the flawed helicopter parenting style, is an approach that promotes independence, personal responsibility and healthy self-esteem; “Panda ...

Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.